Abstract

The introduction of the Continuous Glucose Monitoring (CGM) System, designed for kids aged 2 years and older, emphasized the urgency of addressing the diabetes epidemic and prioritizing the safety and reliability of medical devices such as CGMs. Rigorous testing methods are essential to mitigate potential risks, as errors could severely affect patient health. Explore this white paper to learn the pivotal role of digital assurance in bolstering the safety and effectiveness of medical devices, specifically CGMs, thereby fostering a safer environment in health technology.